Circulating oxidized low-density lipoprotein is an independent predictor for cardiac event in patients with coronary artery disease.

[1]  H. Itabe.  Oxidized low-density lipoproteins: what is understood and what remains to be clarified. , 2003, Biological & pharmaceutical bulletin.

[2]  H. Horiguchi,et al.  Oxidized LDL in Carotid Plaques and Plasma Associates With Plaque Instability , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[3]  Toru Suzuki,et al.  Diagnostic implications of circulating oxidized low density lipoprotein levels as a biochemical risk marker of coronary artery disease. , 2002, Clinical biochemistry.

[4]  D. Steinberg,et al.  Is the Oxidative Modification Hypothesis Relevant to Human Atherosclerosis?: Do the Antioxidant Trials Conducted to Date Refute the Hypothesis? , 2002, Circulation.

[5]  M. Kinoshita,et al.  Plasma oxidized low-density lipoprotein as a prognostic predictor in patients with chronic congestive heart failure. , 2002, Journal of the American College of Cardiology.

[6]  T. Matsuo,et al.  Pathophysiological role of oxidized low-density lipoprotein in plaque instability in coronary artery diseases. , 2002, Journal of diabetes and its complications.

[7]  P. Holvoet,et al.  Oxidized LDL and HDL: antagonists in atherothrombosis , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[8]  F. Van de Werf,et al.  Circulating Oxidized LDL Is a Useful Marker for Identifying Patients With Coronary Artery Disease , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[9]  T. Matsuo,et al.  Elevated Levels of Oxidized Low Density Lipoprotein Show a Positive Relationship With the Severity of Acute Coronary Syndromes , 2001, Circulation.

[10]  K. Kugiyama,et al.  Increase in plasma levels of oxidized low-density lipoproteins in patients with coronary spastic angina. , 2001, Atherosclerosis.

[11]  M. Kurabayashi,et al.  Circulating Oxidized Low Density Lipoprotein Levels: A Biochemical Risk Marker for Coronary Heart Disease , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[12]  A. Hasegawa,et al.  Simple and practical sandwich-type enzyme immunoassay for human oxidatively modified low density lipoprotein using antioxidized phosphatidylcholine monoclonal antibody and antihuman apolipoprotein-B antibody. , 2000, Clinical biochemistry.

[13]  D. Collen,et al.  Oxidized low density lipoprotein is a prognostic marker of transplant-associated coronary artery disease. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[14]  F. Werf,et al.  Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. , 1998, Circulation.

[15]  E. Lesaffre,et al.  Correlation between Oxidized Low Density Lipoproteins and von Willebrand Factor in Chronic Renal Failure , 1996, Thrombosis and Haemostasis.

[16]  J. Witztum,et al.  Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma. , 1996, The Journal of clinical investigation.

[17]  Y. Hata,et al.  Sensitive detection of oxidatively modified low density lipoprotein using a monoclonal antibody. , 1996, Journal of lipid research.

[18]  Y. Yoshida,et al.  A monoclonal antibody against oxidized lipoprotein recognizes foam cells in atherosclerotic lesions. Complex formation of oxidized phosphatidylcholines and polypeptides. , 1994, The Journal of biological chemistry.

[19]  M. Territo,et al.  Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. , 1990, The Journal of clinical investigation.

[20]  G. Cazzolato,et al.  Presence of a Modified Low Density Lipoprotein in Humans , 1988, Arteriosclerosis.